Ilovebenefits’s Blog

Just another WordPress.com weblog

Why We Need an Independent Comparative Effectiveness Institute

Data From Studies of Pfizer Neurontin Drug May Have Been Skewed
Bloomberg – November 11, 2009

Researchers say trials of Pfizer Inc.’s Neurontin epilepsy treatment for uses that were not yet approved may have been skewed to emphasize favorable results.

Advertisements

November 14, 2009 - Posted by | drugs, healthcare, Transparency | , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: